Published on in Vol 9, No 9 (2020): September

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/24074, first published .
Correction: Nurse-Delivered Cognitive Behavioral Therapy for Adherence and Depression Among People Living With HIV (the Ziphamandla Study): Protocol for a Randomized Controlled Trial

Correction: Nurse-Delivered Cognitive Behavioral Therapy for Adherence and Depression Among People Living With HIV (the Ziphamandla Study): Protocol for a Randomized Controlled Trial

Correction: Nurse-Delivered Cognitive Behavioral Therapy for Adherence and Depression Among People Living With HIV (the Ziphamandla Study): Protocol for a Randomized Controlled Trial

Corrigenda and Addenda

1HIV Mental Health Research Unit, Neuroscience Institute, Department of Psychiatry and Mental Health, University of Cape Town, Cape Town, South Africa

2Department of Psychology, University of Miami, Coral Gables, FL, United States

3Department of Psychology, University of Maryland, College Park, MD, United States

4Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States

Corresponding Author:

John A Joska, MBChB, PhD

HIV Mental Health Research Unit, Neuroscience Institute

Department of Psychiatry and Mental Health

University of Cape Town

Groote Schuur Hospital, OPD Building, H-Floor, Rm 30

Groote Schuur Drive, Observatory

Cape Town, 7925

South Africa

Phone: 27 21 404 2164

Email: John.Joska@uct.ac.za



In “Nurse-Delivered Cognitive Behavioral Therapy for Adherence and Depression Among People Living With HIV (the Ziphamandla Study): Protocol for a Randomized Controlled Trial” (JMIR Res Protoc 2020;9(2):e14200) the authors noted one error.

Under the Methods section subheading "Secondary Outcomes: HIV Viral Load and CD4 Cell Count," the lower limit of the range of detection for the COBAS AmpliPrep/TaqMan HIV-1 test was reported incorrectly as 48. The actual lower limit of this test is 20. The original text reporting this value read:

Participants who do not have viral load test results within 1 month of the baseline assessment or 4-, 8-, and 12-month follow-up undergo a blood draw for assay using the COBAS AmpliPrep/TaqMan HIV-1 test (range: 48-10,000,000 copies/mL) [50].

This sentence has been corrected to read:

Participants who do not have viral load test results within 1 month of the baseline assessment or 4-, 8-, and 12-month follow-up undergo a blood draw for assay using the COBAS AmpliPrep/TaqMan HIV-1 test (range: 20-10,000,000 copies/mL) [50].

This change does not affect the overall findings of the paper.

The correction will appear in the online version of the paper on the JMIR Publications website on September 28, 2020, together with the publication of this correction notice. Because this was made after submission to PubMed, PubMed Central, and other full-text repositories, the corrected article has also been resubmitted to those repositories.

Edited by G Eysenbach; This is a non–peer-reviewed article. submitted 02.09.20; accepted 03.09.20; published 28.09.20

Copyright

©John A Joska, Lena S Andersen, Rosana Smith-Alvarez, Jessica Magidson, Jasper S Lee, Conall O'Cleirigh, Steven A Safren. Originally published in JMIR Research Protocols (http://www.researchprotocols.org), 28.09.2020.

This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Research Protocols, is properly cited. The complete bibliographic information, a link to the original publication on http://www.researchprotocols.org, as well as this copyright and license information must be included.